Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA | P35790 | 1/20 | 0.64 |
| ▸ | MELK | Q14680 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | GFER | P55789 | 1/20 | 0.57 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.57 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.57 |
| ▸ | NCF1 | P14598 | 1/20 | 0.57 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.51 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.49 |
| ▸ | PLOD3 | O60568 | 1/20 | 0.49 |
| ▸ | PLOD1 | Q02809 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8918268 | 0.92 | CHKA (0.67) | CHKAMELKALDH1A1GAAKMT2A | |
| SCHEMBL28112415 | 0.88 | CHKA (0.80) | CHKAGAAMAPTKDM4EADRB2 | |
| SCHEMBL28337260 | 0.88 | MELK (0.69) | CHKAMELKALDH1A1GAAKMT2A | |
| SCHEMBL28875268 | 0.83 | MELK (0.52) | CHKAMELKALDH1A1GAAKMT2A | |
| SCHEMBL13189834 | 0.82 | CYP2C9 (0.64) | CHKAALDH1A1 | |
| SCHEMBL18867080 | 0.82 | L3MBTL3 (0.53) | CHKAMELKALDH1A1KMT2AADRB2 | |
| Tert-Butyl Formate SCHEMBL27681794 | 0.82 | ALDH1A1 (0.49) | CHKAMELKALDH1A1GAAKMT2A | |
| SCHEMBL171845 | 0.80 | MAPT (0.63) | CHKAMELKALDH1A1GAAKMT2A | |
| SCHEMBL13977101 | 0.79 | MELK (0.56) | MELKALDH1A1GAAKMT2AADRA2C | |
| SCHEMBL18590696 | 0.79 | CHKA (0.67) | CHKAGAAMAPTKDM4EADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1877401-A2 | NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM | Elan Pharmaceuticals Inc. (US) | 2008-01-16 | — | — | EP | claimed |
| US-20070032475-A1 | Novel compounds useful for bradykinin B1 receptor antagonism | ELAN PHARMACEUTICALS, INC. | 2007-02-08 | — | — | US | claimed |
| WO-2006113140-A2 | NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM | ELAN PHARMACEUTICALS, INC. (US) | 2006-10-26 | — | — | WO | claimed |
| US-4761467-A | REACTING METHANOL, CARBON MONOXIDE AND OXYGEN TO PRODUCE DIMETHYL CARBONATE WITH A CUPRIC METHOXYCHLORIDE-PYRIDINE COMPOUND CATALYST | TEXACO INC. (US) | 1988-08-02 | — | — | US | claimed |
| EP-0074837-A1 | 4-Substituted pyridine catalysts | REILLY TAR & CHEMICAL CORPORATION (US) | 1983-03-23 | — | — | EP | claimed |
| EP-4534538-A2 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | Vertex Pharmaceuticals Incorporated (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-4190786-B1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMA (US) | 2025-02-26 | — | — | EP | disclosed |
| EP-3647311-B1 | RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2023-11-01 | — | — | EP | disclosed |
| WO-2023107648-A2 | SYNTHESIS OF ESTER, CARBONATE, AND CARBAMATE-DERIVED NOVEL BIODEGRADABLE IONIZABLE LIPIDS FROM METHYL RICINOLEATE OR METHYL 12-HYDROXYSTEARATE AND ITS APPLICATIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-15 | — | — | WO | disclosed |
| EP-4190786-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | Vertex Pharmaceuticals Incorporated (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20230109839-A1 | THERAPEUTIC AGENT FOR TAUOPATHIES | Sumitomo Pharma Co., Ltd. (JP) | 2023-04-13 | — | — | US | disclosed |
| EP-3808749-B1 | PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS INHIBITORS OF ATR KINASE FOR THE TREATMENT OF CANCER DISEASES | VERTEX PHARMA (US) | 2023-03-08 | — | — | EP | disclosed |
| US-5444163-A | Preparation of reactive phthalocyanine dyes | BASF AKTIENGESELLSCHAFT (DE) | 1995-08-22 | — | — | US | disclosed |
| EP-0602562-A1 | Process for the preparation of phthalocyanine reactive dyes | BASF Aktiengesellschaft (DE) | 1994-06-22 | — | — | EP | disclosed |
| EP-0597411-A1 | Process for the preparation of phthalocyanine reactive dyes | BASF Aktiengesellschaft (DE) | 1994-05-18 | — | — | EP | disclosed |
| US-5215967-A | AMINOACID DERIVATIVES INHIBITING RENIN | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-06-01 | — | — | US | disclosed |
| US-4761467-A | REACTING METHANOL, CARBON MONOXIDE AND OXYGEN TO PRODUCE DIMETHYL CARBONATE WITH A CUPRIC METHOXYCHLORIDE-PYRIDINE COMPOUND CATALYST | TEXACO INC. (US) | 1988-08-02 | — | — | US | disclosed |
| EP-0217651-A2 | Preparation of organic carbonates | TEXACO DEVELOPMENT CORPORATION (US) | 1987-04-08 | — | — | EP | disclosed |
| EP-0074837-A1 | 4-Substituted pyridine catalysts | REILLY TAR & CHEMICAL CORPORATION (US) | 1983-03-23 | — | — | EP | disclosed |
| EP-0074837-A1 | 4-Substituted pyridine catalysts | REILLY TAR & CHEMICAL CORPORATION (US) | 1983-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230109839-A1 | THERAPEUTIC AGENT FOR TAUOPATHIES | MAPT, PSEN1, PSEN2 | CHKA 886/4885MELK 2392/4885ALDH1A1 4081/4885 |
| US-20070032475-A1 | Novel compounds useful for bradykinin B1 receptor antagonism | BDKRB1, BDKRB2, NPBWR1 | CHKA 1031/4885MELK 1330/4885ALDH1A1 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.